DARPA has announced that it has selected three performer teams to support the Harnessing Enzymatic Activity for Lifesaving Remedies (HEALR) program. Groups from Yale University, University of Washington, and Broad Institute plan to utilise a new therapeutic approach and novel protein degradation strategies/modalities to permit a flexible and rapid response for ...